Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban PK in Post-Pancreaticoduodenectomy Patients
NCT04191928Phase 1Completed
- Sponsor
- Thomas Jefferson University
- Start
- Mar 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of apixaban in deep vein thrombosis (DVT) and pulmonary embolism (PE), sponsored by Thomas Jefferson University. Primary endpoint: Serum Apixaban. Started Mar 2020; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04191928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04191928.